The round involved a syndicate of leading international life sciences investors led by Novartis Venture Fund and Columbus Venture Partners, and including Roche Venture Fund, HealthCap, Kurma Partners ...
BioClin Therapeutics, Inc., a privately-‐held clinical stage drug development company developing a first-‐in-‐class anti-‐FGFR3 (fibroblast growth factor receptor 3) monoclonal antibod...
Forbion Capital Partners (NL) and Seroba Life Sciences (IE) co-led the financing round, which includes current investors Merck Ventures (NL), Ysios Capital (ES) and Sunstone Capital (DK). Marco Boorsm...
TiGenix has announced that it intends to offer and sell, subject to market and other conditions, 2.75 million American Depositary Shares representing 55 million ordinary shares in an initial public o...
The investment round is co-led by Life Sciences Partners, Netherlands, Ysios Capital, Spain, Sunstone Capital, Denmark, and Flerie Invest, Sweden, in addition to current shareholders Kurma Partners, F...
Existing shareholders including Sofinnova Partners, Bpifrance and Seventure were joined by two new investors: Novo Seeds, which led the round, and Ysios Capital
Ysios BioFund II Innvierte cuenta con una sólida base de inversores entre los que se encuentran: CDTI a través de su programa Innvierte, Fondo Europeo de Inversiones a través de InnovFin SME Ventur...
The round of financing consisted of expanded funding commitments from its existing investors: Advent Partners, Chiesi Ventures, Ysios Capital, Alexandria Venture Investments and several individual inv...
CVRx, Inc., a private medical device company, has secured equity financing totaling $93 million and a new $20 million debt facility. CVRx plans to use the proceeds for the primary purposes of completi...
Las grandes gestoras de fondos de capital con sede en Barcelona confían en captar este año alrededor de 1.100 millones de euros para invertir en empresas. Esa es la cantidad con la que ya cuentan en...
Kala was founded by leaders in the fields of nanomedicine and biopharmaceutical engineering, and is backed by leading life sciences investors including Longitude Capital, OrbiMed, Vivo Capital, CAM Ca...